Global Peptide CDMO Supply, Demand and Key Producers, 2023-2029

Description

The global Peptide CDMO market size is expected to reach $ 8327.1 million by 2029, rising at a market growth of 14.3% CAGR during the forecast period (2023-2029).

Global key peptide CDMO producers include Bachem, PolyPeptide, CordenPharma, and others. The top five manufacturers together account for 40% of the market share, with the largest manufacturer being Bachem with 17%. At the sales level, North America is the largest sales market with a market share of over 50%, followed by Europe and China with 33% and 9% respectively. In terms of product categories, it is divided into APIs and intermediates and FDF, with the former holding the major market share of 67%. In terms of application, commercial is the top application area with a market share of 76%, followed by academic research institutions.

Peptides are synthesized by coupling the carboxyl group of one amino acid to the amino group of another amino acid molecule. Due to the possibility of unintended reactions, protecting groups are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.

A contract development and manufacturing company (CDMO) is a company within the pharmaceutical industry that provides drug development and manufacturing services. Pharmaceutical companies partner with CDMOs as a way to outsource drug development and drug manufacturing.

CDMO peptides production via contract peptide manufacturing is to optimize process development and achieve highly efficient conversion at every amino acid coupling to produce a high-purity crude synthetic custom peptide and minimize the demands on downstream processing.

This report studies the global Peptide CDMO demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Peptide CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Peptide CDMO that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Peptide CDMO total market, 2018-2029, (USD Million)
Global Peptide CDMO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Peptide CDMO total market, key domestic companies and share, (USD Million)
Global Peptide CDMO revenue by player and market share 2018-2023, (USD Million)
Global Peptide CDMO total market by Type, CAGR, 2018-2029, (USD Million)
Global Peptide CDMO total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Peptide CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermofischer, Bio Basic, JPT and Genscript, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Peptide CDMO market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Peptide CDMO Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Peptide CDMO Market, Segmentation by Type
    APIs and Intermediates
    FDF

Global Peptide CDMO Market, Segmentation by Application
    Commercial
    Academic Research
    Other

Companies Profiled:
    Bachem
    PolyPeptide
    CordenPharma
    AmbioPharm
    USV Peptides
    Thermofischer
    Bio Basic
    JPT
    Genscript
    Xinbang Pharma
    ScinoPharm
    SN Biopharm
    CBL
    Piramal Pharma
    CPC Scientific

Key Questions Answered
1. How big is the global Peptide CDMO market?
2. What is the demand of the global Peptide CDMO market?
3. What is the year over year growth of the global Peptide CDMO market?
4. What is the total value of the global Peptide CDMO market?
5. Who are the major players in the global Peptide CDMO market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Peptide CDMO Introduction
    1.2 World Peptide CDMO Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Peptide CDMO Total Market by Region (by Headquarter Location)
        1.3.1 World Peptide CDMO Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Peptide CDMO Market Size (2018-2029)
        1.3.3 China Peptide CDMO Market Size (2018-2029)
        1.3.4 Europe Peptide CDMO Market Size (2018-2029)
        1.3.5 Japan Peptide CDMO Market Size (2018-2029)
        1.3.6 South Korea Peptide CDMO Market Size (2018-2029)
        1.3.7 ASEAN Peptide CDMO Market Size (2018-2029)
        1.3.8 India Peptide CDMO Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Peptide CDMO Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Peptide CDMO Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Peptide CDMO Consumption Value (2018-2029)
    2.2 World Peptide CDMO Consumption Value by Region
        2.2.1 World Peptide CDMO Consumption Value by Region (2018-2023)
        2.2.2 World Peptide CDMO Consumption Value Forecast by Region (2024-2029)
    2.3 United States Peptide CDMO Consumption Value (2018-2029)
    2.4 China Peptide CDMO Consumption Value (2018-2029)
    2.5 Europe Peptide CDMO Consumption Value (2018-2029)
    2.6 Japan Peptide CDMO Consumption Value (2018-2029)
    2.7 South Korea Peptide CDMO Consumption Value (2018-2029)
    2.8 ASEAN Peptide CDMO Consumption Value (2018-2029)
    2.9 India Peptide CDMO Consumption Value (2018-2029)

3 World Peptide CDMO Companies Competitive Analysis
    3.1 World Peptide CDMO Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Peptide CDMO Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Peptide CDMO in 2022
        3.2.3 Global Concentration Ratios (CR8) for Peptide CDMO in 2022
    3.3 Peptide CDMO Company Evaluation Quadrant
    3.4 Peptide CDMO Market: Overall Company Footprint Analysis
        3.4.1 Peptide CDMO Market: Region Footprint
        3.4.2 Peptide CDMO Market: Company Product Type Footprint
        3.4.3 Peptide CDMO Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Peptide CDMO Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Peptide CDMO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Peptide CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Peptide CDMO Consumption Value Comparison
        4.2.1 United States VS China: Peptide CDMO Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Peptide CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Peptide CDMO Companies and Market Share, 2018-2023
        4.3.1 United States Based Peptide CDMO Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Peptide CDMO Revenue, (2018-2023)
    4.4 China Based Companies Peptide CDMO Revenue and Market Share, 2018-2023
        4.4.1 China Based Peptide CDMO Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Peptide CDMO Revenue, (2018-2023)
    4.5 Rest of World Based Peptide CDMO Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Peptide CDMO Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Peptide CDMO Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Peptide CDMO Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 APIs and Intermediates
        5.2.2 FDF
    5.3 Market Segment by Type
        5.3.1 World Peptide CDMO Market Size by Type (2018-2023)
        5.3.2 World Peptide CDMO Market Size by Type (2024-2029)
        5.3.3 World Peptide CDMO Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Peptide CDMO Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Commercial
        6.2.2 Academic Research
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Peptide CDMO Market Size by Application (2018-2023)
        6.3.2 World Peptide CDMO Market Size by Application (2024-2029)
        6.3.3 World Peptide CDMO Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Bachem
        7.1.1 Bachem Details
        7.1.2 Bachem Major Business
        7.1.3 Bachem Peptide CDMO Product and Services
        7.1.4 Bachem Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Bachem Recent Developments/Updates
        7.1.6 Bachem Competitive Strengths & Weaknesses
    7.2 PolyPeptide
        7.2.1 PolyPeptide Details
        7.2.2 PolyPeptide Major Business
        7.2.3 PolyPeptide Peptide CDMO Product and Services
        7.2.4 PolyPeptide Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 PolyPeptide Recent Developments/Updates
        7.2.6 PolyPeptide Competitive Strengths & Weaknesses
    7.3 CordenPharma
        7.3.1 CordenPharma Details
        7.3.2 CordenPharma Major Business
        7.3.3 CordenPharma Peptide CDMO Product and Services
        7.3.4 CordenPharma Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 CordenPharma Recent Developments/Updates
        7.3.6 CordenPharma Competitive Strengths & Weaknesses
    7.4 AmbioPharm
        7.4.1 AmbioPharm Details
        7.4.2 AmbioPharm Major Business
        7.4.3 AmbioPharm Peptide CDMO Product and Services
        7.4.4 AmbioPharm Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 AmbioPharm Recent Developments/Updates
        7.4.6 AmbioPharm Competitive Strengths & Weaknesses
    7.5 USV Peptides
        7.5.1 USV Peptides Details
        7.5.2 USV Peptides Major Business
        7.5.3 USV Peptides Peptide CDMO Product and Services
        7.5.4 USV Peptides Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 USV Peptides Recent Developments/Updates
        7.5.6 USV Peptides Competitive Strengths & Weaknesses
    7.6 Thermofischer
        7.6.1 Thermofischer Details
        7.6.2 Thermofischer Major Business
        7.6.3 Thermofischer Peptide CDMO Product and Services
        7.6.4 Thermofischer Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Thermofischer Recent Developments/Updates
        7.6.6 Thermofischer Competitive Strengths & Weaknesses
    7.7 Bio Basic
        7.7.1 Bio Basic Details
        7.7.2 Bio Basic Major Business
        7.7.3 Bio Basic Peptide CDMO Product and Services
        7.7.4 Bio Basic Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Bio Basic Recent Developments/Updates
        7.7.6 Bio Basic Competitive Strengths & Weaknesses
    7.8 JPT
        7.8.1 JPT Details
        7.8.2 JPT Major Business
        7.8.3 JPT Peptide CDMO Product and Services
        7.8.4 JPT Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 JPT Recent Developments/Updates
        7.8.6 JPT Competitive Strengths & Weaknesses
    7.9 Genscript
        7.9.1 Genscript Details
        7.9.2 Genscript Major Business
        7.9.3 Genscript Peptide CDMO Product and Services
        7.9.4 Genscript Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Genscript Recent Developments/Updates
        7.9.6 Genscript Competitive Strengths & Weaknesses
    7.10 Xinbang Pharma
        7.10.1 Xinbang Pharma Details
        7.10.2 Xinbang Pharma Major Business
        7.10.3 Xinbang Pharma Peptide CDMO Product and Services
        7.10.4 Xinbang Pharma Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Xinbang Pharma Recent Developments/Updates
        7.10.6 Xinbang Pharma Competitive Strengths & Weaknesses
    7.11 ScinoPharm
        7.11.1 ScinoPharm Details
        7.11.2 ScinoPharm Major Business
        7.11.3 ScinoPharm Peptide CDMO Product and Services
        7.11.4 ScinoPharm Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 ScinoPharm Recent Developments/Updates
        7.11.6 ScinoPharm Competitive Strengths & Weaknesses
    7.12 SN Biopharm
        7.12.1 SN Biopharm Details
        7.12.2 SN Biopharm Major Business
        7.12.3 SN Biopharm Peptide CDMO Product and Services
        7.12.4 SN Biopharm Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 SN Biopharm Recent Developments/Updates
        7.12.6 SN Biopharm Competitive Strengths & Weaknesses
    7.13 CBL
        7.13.1 CBL Details
        7.13.2 CBL Major Business
        7.13.3 CBL Peptide CDMO Product and Services
        7.13.4 CBL Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 CBL Recent Developments/Updates
        7.13.6 CBL Competitive Strengths & Weaknesses
    7.14 Piramal Pharma
        7.14.1 Piramal Pharma Details
        7.14.2 Piramal Pharma Major Business
        7.14.3 Piramal Pharma Peptide CDMO Product and Services
        7.14.4 Piramal Pharma Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Piramal Pharma Recent Developments/Updates
        7.14.6 Piramal Pharma Competitive Strengths & Weaknesses
    7.15 CPC Scientific
        7.15.1 CPC Scientific Details
        7.15.2 CPC Scientific Major Business
        7.15.3 CPC Scientific Peptide CDMO Product and Services
        7.15.4 CPC Scientific Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 CPC Scientific Recent Developments/Updates
        7.15.6 CPC Scientific Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Peptide CDMO Industry Chain
    8.2 Peptide CDMO Upstream Analysis
    8.3 Peptide CDMO Midstream Analysis
    8.4 Peptide CDMO Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Peptide CDMO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Peptide CDMO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Peptide CDMO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Peptide CDMO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Peptide CDMO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Peptide CDMO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Peptide CDMO Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Peptide CDMO Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Peptide CDMO Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Peptide CDMO Players in 2022
    Table 12. World Peptide CDMO Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Peptide CDMO Company Evaluation Quadrant
    Table 14. Head Office of Key Peptide CDMO Player
    Table 15. Peptide CDMO Market: Company Product Type Footprint
    Table 16. Peptide CDMO Market: Company Product Application Footprint
    Table 17. Peptide CDMO Mergers & Acquisitions Activity
    Table 18. United States VS China Peptide CDMO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Peptide CDMO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Peptide CDMO Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Peptide CDMO Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Peptide CDMO Revenue Market Share (2018-2023)
    Table 23. China Based Peptide CDMO Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Peptide CDMO Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Peptide CDMO Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Peptide CDMO Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Peptide CDMO Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Peptide CDMO Revenue Market Share (2018-2023)
    Table 29. World Peptide CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Peptide CDMO Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Peptide CDMO Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Peptide CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Peptide CDMO Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Peptide CDMO Market Size by Application (2024-2029) & (USD Million)
    Table 35. Bachem Basic Information, Area Served and Competitors
    Table 36. Bachem Major Business
    Table 37. Bachem Peptide CDMO Product and Services
    Table 38. Bachem Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Bachem Recent Developments/Updates
    Table 40. Bachem Competitive Strengths & Weaknesses
    Table 41. PolyPeptide Basic Information, Area Served and Competitors
    Table 42. PolyPeptide Major Business
    Table 43. PolyPeptide Peptide CDMO Product and Services
    Table 44. PolyPeptide Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. PolyPeptide Recent Developments/Updates
    Table 46. PolyPeptide Competitive Strengths & Weaknesses
    Table 47. CordenPharma Basic Information, Area Served and Competitors
    Table 48. CordenPharma Major Business
    Table 49. CordenPharma Peptide CDMO Product and Services
    Table 50. CordenPharma Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. CordenPharma Recent Developments/Updates
    Table 52. CordenPharma Competitive Strengths & Weaknesses
    Table 53. AmbioPharm Basic Information, Area Served and Competitors
    Table 54. AmbioPharm Major Business
    Table 55. AmbioPharm Peptide CDMO Product and Services
    Table 56. AmbioPharm Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. AmbioPharm Recent Developments/Updates
    Table 58. AmbioPharm Competitive Strengths & Weaknesses
    Table 59. USV Peptides Basic Information, Area Served and Competitors
    Table 60. USV Peptides Major Business
    Table 61. USV Peptides Peptide CDMO Product and Services
    Table 62. USV Peptides Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. USV Peptides Recent Developments/Updates
    Table 64. USV Peptides Competitive Strengths & Weaknesses
    Table 65. Thermofischer Basic Information, Area Served and Competitors
    Table 66. Thermofischer Major Business
    Table 67. Thermofischer Peptide CDMO Product and Services
    Table 68. Thermofischer Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Thermofischer Recent Developments/Updates
    Table 70. Thermofischer Competitive Strengths & Weaknesses
    Table 71. Bio Basic Basic Information, Area Served and Competitors
    Table 72. Bio Basic Major Business
    Table 73. Bio Basic Peptide CDMO Product and Services
    Table 74. Bio Basic Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Bio Basic Recent Developments/Updates
    Table 76. Bio Basic Competitive Strengths & Weaknesses
    Table 77. JPT Basic Information, Area Served and Competitors
    Table 78. JPT Major Business
    Table 79. JPT Peptide CDMO Product and Services
    Table 80. JPT Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. JPT Recent Developments/Updates
    Table 82. JPT Competitive Strengths & Weaknesses
    Table 83. Genscript Basic Information, Area Served and Competitors
    Table 84. Genscript Major Business
    Table 85. Genscript Peptide CDMO Product and Services
    Table 86. Genscript Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Genscript Recent Developments/Updates
    Table 88. Genscript Competitive Strengths & Weaknesses
    Table 89. Xinbang Pharma Basic Information, Area Served and Competitors
    Table 90. Xinbang Pharma Major Business
    Table 91. Xinbang Pharma Peptide CDMO Product and Services
    Table 92. Xinbang Pharma Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Xinbang Pharma Recent Developments/Updates
    Table 94. Xinbang Pharma Competitive Strengths & Weaknesses
    Table 95. ScinoPharm Basic Information, Area Served and Competitors
    Table 96. ScinoPharm Major Business
    Table 97. ScinoPharm Peptide CDMO Product and Services
    Table 98. ScinoPharm Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. ScinoPharm Recent Developments/Updates
    Table 100. ScinoPharm Competitive Strengths & Weaknesses
    Table 101. SN Biopharm Basic Information, Area Served and Competitors
    Table 102. SN Biopharm Major Business
    Table 103. SN Biopharm Peptide CDMO Product and Services
    Table 104. SN Biopharm Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. SN Biopharm Recent Developments/Updates
    Table 106. SN Biopharm Competitive Strengths & Weaknesses
    Table 107. CBL Basic Information, Area Served and Competitors
    Table 108. CBL Major Business
    Table 109. CBL Peptide CDMO Product and Services
    Table 110. CBL Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. CBL Recent Developments/Updates
    Table 112. CBL Competitive Strengths & Weaknesses
    Table 113. Piramal Pharma Basic Information, Area Served and Competitors
    Table 114. Piramal Pharma Major Business
    Table 115. Piramal Pharma Peptide CDMO Product and Services
    Table 116. Piramal Pharma Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Piramal Pharma Recent Developments/Updates
    Table 118. CPC Scientific Basic Information, Area Served and Competitors
    Table 119. CPC Scientific Major Business
    Table 120. CPC Scientific Peptide CDMO Product and Services
    Table 121. CPC Scientific Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 122. Global Key Players of Peptide CDMO Upstream (Raw Materials)
    Table 123. Peptide CDMO Typical Customers
List of Figure
    Figure 1. Peptide CDMO Picture
    Figure 2. World Peptide CDMO Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Peptide CDMO Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Peptide CDMO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Peptide CDMO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Peptide CDMO Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Peptide CDMO Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Peptide CDMO Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Peptide CDMO Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Peptide CDMO Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Peptide CDMO Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Peptide CDMO Revenue (2018-2029) & (USD Million)
    Figure 13. Peptide CDMO Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Peptide CDMO Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Peptide CDMO by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Peptide CDMO Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Peptide CDMO Markets in 2022
    Figure 27. United States VS China: Peptide CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Peptide CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Peptide CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Peptide CDMO Market Size Market Share by Type in 2022
    Figure 31. APIs and Intermediates
    Figure 32. FDF
    Figure 33. World Peptide CDMO Market Size Market Share by Type (2018-2029)
    Figure 34. World Peptide CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World Peptide CDMO Market Size Market Share by Application in 2022
    Figure 36. Commercial
    Figure 37. Academic Research
    Figure 38. Other
    Figure 39. Peptide CDMO Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Companies Mentioned

Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific